Cipla informs about press release

07 Jul 2023 Evaluate

Cipla has informed that it enclosed press release dated 7th July 2023 titled ‘Voluntary nationwide recall of six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to container defect by Cipla USA Inc., wholly owned step down subsidiary of the Company in USA’.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1404.00 4.65 (0.33%)
18-May-2024 09:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1533.00
Dr. Reddys Lab 5842.50
Cipla 1404.00
Zydus Lifesciences 1104.45
Lupin 1655.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.